Submitted by Anonymous (not verified) on 25 September 2024 - 16:05
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Status: Authorised